Imatinib-d8 (STI571 D8) is a 2H-labeled version of Imatinib. Imatinib is a multi-target receptor tyrosine kinase inhibitor with anti-tumor activity, selectively inhibiting BCR-ABL, v-Abl, PDGFR, c-kit kinases, and is used in chronic myeloid leukemia treatment.
Molecular Weight:
501.65
CAS Number:
[1092942-82-9]
Formula:
C29H23D8N7O
Target:
PDGFR|||Autophagy|||SARS-CoV|||c-Kit|||Bcr-Abl
T11640
* VAT and and shipping costs not included. Errors and price changes excepted